Last update 16 May 2025

HNC-042

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HNC 042, HNC042, ZBD 042
+ [2]
Target
Influenza A neuraminidase
Action
inhibitors
Mechanism
neuraminidase inhibitors(Influenza A Neuraminidase inhibitors)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Influenza, Human
Inactive Indication-
Originator Organization
Constant Connaught Medical Technology Co.,Ltd. In Guangzhou CityConstant Connaught Medical Technology Co.,Ltd. In Guangzhou City
Active Organization
Constant Connaught Medical Technology Co.,Ltd. In Guangzhou CityConstant Connaught Medical Technology Co.,Ltd. In Guangzhou CityHeiLongJiang ZBD Pharmaceutical Co., Ltd.HeiLongJiang ZBD Pharmaceutical Co., Ltd.ZHENBAODAO Groups Co., Ltd.
Inactive Organization-
License Organization
HeiLongJiang ZBD Pharmaceutical Co., Ltd.HeiLongJiang ZBD Pharmaceutical Co., Ltd.Constant Connaught Medical Technology Co.,Ltd. In Guangzhou CityConstant Connaught Medical Technology Co.,Ltd. In Guangzhou City
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with HNC-042
NCT04603989
/ CompletedPhase 1
A Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, Multiple Ascending Doses Study Following Intravenous Administration in Healthy Chinese Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of HNC042
NCT03740555
/ CompletedPhase 1
A Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, Single and Multiple Ascending Doses (SAD/MAD) Study Following Intravenous Administration in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of HNC042.
100 Clinical Results associated with HNC-042
Login to view more data
100 Translational Medicine associated with HNC-042
Login to view more data
100 Patents (Medical) associated with HNC-042
Login to view more data
100 Deals associated with HNC-042
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanPhase 2
China
ZHENBAODAO Groups Co., Ltd.
-
Influenza, HumanPhase 2-
Constant Connaught Medical Technology Co.,Ltd. In Guangzhou CityConstant Connaught Medical Technology Co.,Ltd. In Guangzhou City
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free